Monday - April 13, 2026

ENDRA Life Sciences (NASDAQ: NDRA) Targets Billions With TAEUS® Liver Imaging Technology

As the global race to treat metabolic dysfunction–associated steatotic liver disease (MASLD) and expand GLP-1 therapies accelerates, a critical challenge is emerging across the pharmaceutical industry: clinical trial infrastructure is struggling to scale—especially liver imaging. With trial sizes increasing, durations … Continue reading

Undervalued OTC Stocks Radar: ADMQ, ADIA, RDTCF, BFGFF, ROKRF Gaining Investor Attention in 2026

A new wave of undervalued OTC and small-cap stocks is beginning to surface across sectors including manufacturing, biotech, mining, and energy, as investors search for early-stage opportunities with real catalysts. Names like ADM Endeavors (OTCQB: ADMQ), Adia Nutrition Inc. (OTCQB: … Continue reading